D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 48 Citations 9,850 94 World Ranking 2904 National Ranking 1372

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Antibody
  • Immune system

Tucker W. LeBien spends much of his time researching Molecular biology, Monoclonal antibody, Antibody, Leukemia and Antigen. His research in Molecular biology intersects with topics in Cell culture, Surface Immunoglobulin, B cell, Immunoglobulin light chain and Receptor. His Cell culture study combines topics in areas such as Complement receptor, Chromosome 12 and Chromosomal translocation.

His Monoclonal antibody study combines topics in areas such as T lymphocyte, CD43, Bone marrow and Virology. Tucker W. LeBien interconnects Surgery, Transplantation, Stem cell and Acute lymphocytic leukemia in the investigation of issues within Bone marrow. His Antibody research incorporates themes from Kidney and Pathology.

His most cited work include:

  • The Molecular Taxonomy of Primary Prostate Cancer (1426 citations)
  • B lymphocytes: how they develop and function (753 citations)
  • Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. (533 citations)

What are the main themes of his work throughout his whole career to date?

Tucker W. LeBien mainly investigates Molecular biology, Immunology, Monoclonal antibody, Bone marrow and Antibody. His work carried out in the field of Molecular biology brings together such families of science as Cell culture, Receptor, Antigen and B cell. As a member of one scientific family, Tucker W. LeBien mostly works in the field of Antigen, focusing on Leukemia and, on occasion, Chromosomal translocation.

His studies in Immunology integrate themes in fields like Lymphopoiesis and CD40. His research investigates the connection with Bone marrow and areas like Stem cell which intersect with concerns in Cord blood. His study in Antibody is interdisciplinary in nature, drawing from both Phenotype, Cell, Cytotoxic T cell and Chromosome 12.

He most often published in these fields:

  • Molecular biology (46.87%)
  • Immunology (32.50%)
  • Monoclonal antibody (28.12%)

What were the highlights of his more recent work (between 1999-2019)?

  • Molecular biology (46.87%)
  • Immunology (32.50%)
  • Stromal cell (17.50%)

In recent papers he was focusing on the following fields of study:

Molecular biology, Immunology, Stromal cell, Cell biology and Stem cell are his primary areas of study. Tucker W. LeBien is involved in the study of Molecular biology that focuses on CD19 in particular. His Immunology study combines topics from a wide range of disciplines, such as Neuraminic acid, Cancer research and CD40.

His Stromal cell research is multidisciplinary, incorporating perspectives in Severe combined immunodeficiency, Cytokine, Cellular differentiation and Cell–cell interaction. His Cell biology research also works with subjects such as

  • Antibody that intertwine with fields like Antigen,
  • Apoptosis which is related to area like Cell, Cell culture and Mechanism of action. His Haematopoiesis research is multidisciplinary, incorporating elements of Primary immunodeficiency and Bone marrow.

Between 1999 and 2019, his most popular works were:

  • The Molecular Taxonomy of Primary Prostate Cancer (1426 citations)
  • B lymphocytes: how they develop and function (753 citations)
  • Fates of Human B-cell Precursors (219 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Antibody

His primary scientific interests are in Immunology, Molecular biology, Cell biology, Stromal cell and Stem cell. His studies in Antigen, Autoimmune disease, Hematology and Antibody are all subfields of Immunology research. His Molecular biology research includes themes of Cord blood and Mechanism of action.

His studies deal with areas such as Apoptosis and B cell as well as Cell biology. His study looks at the relationship between Stromal cell and fields such as Cellular differentiation, as well as how they intersect with chemical problems. Tucker W. LeBien has included themes like Endothelial stem cell and Bone marrow in his Stem cell study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally.
Cell (2015)

1243 Citations

B lymphocytes: how they develop and function

Tucker W. LeBien;Thomas F. Tedder.
Blood (2008)

973 Citations

Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins.

S J Korsmeyer;A Arnold;A Bakhshi;J V Ravetch.
Journal of Clinical Investigation (1983)

630 Citations

A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage.

C. S. Abramson;J. H. Kersey;Tucker W LeBien.
Journal of Immunology (1981)

541 Citations

P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody.

John H. Kersey;Tucker W. Lebien;Candice S. Abramson;Roland Newman.
Journal of Experimental Medicine (1981)

516 Citations

Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.

John H. Kersey;Daniel Weisdorf;Mark E. Nesbit;Tucker W. LeBien.
The New England Journal of Medicine (1987)

449 Citations

Characterization of a leukemic cell line of the pre‐B phenotype

Richard Hurwitz;Richard Hurwitz;John Hozier;John Hozier;Tucker W LeBien;Tucker W LeBien;Jun Minowada;Jun Minowada.
International Journal of Cancer (1979)

340 Citations

Fates of Human B-cell Precursors

Tucker W. LeBien.
Blood (2000)

333 Citations

The common acute lymphoblastic leukemia antigen (CD10)--emancipation from a functional enigma.

Tucker W LeBien;R. T. McCormack.
Blood (1989)

298 Citations

Interstitial mononuclear cell populations in renal graft rejection. Identification by monoclonal antibodies in tissue sections

J. L. Platt;Tucker W LeBien;A. F. Michael.
Journal of Experimental Medicine (1982)

243 Citations

Best Scientists Citing Tucker W. LeBien

Mark A. Rubin

Mark A. Rubin

University of Bern

Publications: 78

Francesca Demichelis

Francesca Demichelis

University of Trento

Publications: 55

Paul C. Boutros

Paul C. Boutros

University of California, Los Angeles

Publications: 47

Andrea Sboner

Andrea Sboner

Cornell University

Publications: 46

Himisha Beltran

Himisha Beltran

Harvard University

Publications: 45

Thomas F. Tedder

Thomas F. Tedder

Duke University

Publications: 44

Fatih M. Uckun

Fatih M. Uckun

University of Southern California

Publications: 43

Max D. Cooper

Max D. Cooper

Emory University

Publications: 40

Massimo Loda

Massimo Loda

Cornell University

Publications: 40

John H. Kersey

John H. Kersey

University of Minnesota

Publications: 39

Johann S. de Bono

Johann S. de Bono

Institute of Cancer Research

Publications: 37

Jerome Ritz

Jerome Ritz

Harvard University

Publications: 37

Peter S. Nelson

Peter S. Nelson

Fred Hutchinson Cancer Research Center

Publications: 35

Lee M. Nadler

Lee M. Nadler

Harvard University

Publications: 32

Robert G. Bristow

Robert G. Bristow

University of Manchester

Publications: 31

Ching-Hon Pui

Ching-Hon Pui

St. Jude Children's Research Hospital

Publications: 30

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.